These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 9751413

  • 21. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix.
    Zhu H, Mitsuhashi N, Klein A, Barsky LW, Weinberg K, Barr ML, Demetriou A, Wu GD.
    Stem Cells; 2006 Apr; 24(4):928-35. PubMed ID: 16306150
    [Abstract] [Full Text] [Related]

  • 22. The CD44 receptor of the mouse LB T-cell lymphoma: analysis of the isoform repertoire and ligand binding properties by reverse-transcriptase polymerase chain reaction and antisense oligonucleotides.
    Wallach SB, Friedmann A, Naor D.
    Cancer Detect Prev; 2000 Apr; 24(1):33-45. PubMed ID: 10757121
    [Abstract] [Full Text] [Related]

  • 23. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.
    Harrison GM, Davies G, Martin TA, Mason MD, Jiang WG.
    Oncol Rep; 2006 Jan; 15(1):199-206. PubMed ID: 16328056
    [Abstract] [Full Text] [Related]

  • 24. CD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasiveness.
    Herrera-Gayol A, Jothy S.
    Exp Mol Pathol; 1999 Apr; 66(1):99-108. PubMed ID: 10331969
    [Abstract] [Full Text] [Related]

  • 25. Hyaluronan-CD44 promotes phospholipase C-mediated Ca2+ signaling and cisplatin resistance in head and neck cancer.
    Wang SJ, Bourguignon LY.
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):19-24. PubMed ID: 16415424
    [Abstract] [Full Text] [Related]

  • 26. The role of CD44 during CD40 ligand-induced dendritic cell clustering and maturation.
    Termeer C, Johannsen H, Braun T, Renkl A, Ahrens T, Denfeld RW, Lappin MB, Weiss JM, Simon JC.
    J Leukoc Biol; 2001 Nov; 70(5):715-22. PubMed ID: 11698490
    [Abstract] [Full Text] [Related]

  • 27. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
    Afify AM, Stern R, Michael CW.
    Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337
    [Abstract] [Full Text] [Related]

  • 28. Interaction between CD44 and the repeat domain of ankyrin promotes hyaluronic acid-mediated ovarian tumor cell migration.
    Zhu D, Bourguignon LY.
    J Cell Physiol; 2000 May; 183(2):182-95. PubMed ID: 10737894
    [Abstract] [Full Text] [Related]

  • 29. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination.
    Naor D, Wallach-Dayan SB, Zahalka MA, Sionov RV.
    Semin Cancer Biol; 2008 Aug; 18(4):260-7. PubMed ID: 18467123
    [Abstract] [Full Text] [Related]

  • 30. Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival.
    Kayastha S, Freedman AN, Piver MS, Mukkamalla J, Romero-Guittierez M, Werness BA.
    Clin Cancer Res; 1999 May; 5(5):1073-6. PubMed ID: 10353740
    [Abstract] [Full Text] [Related]

  • 31. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44.
    Kim HR, Wheeler MA, Wilson CM, Iida J, Eng D, Simpson MA, McCarthy JB, Bullard KM.
    Cancer Res; 2004 Jul 01; 64(13):4569-76. PubMed ID: 15231668
    [Abstract] [Full Text] [Related]

  • 32. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.
    Singh LS, Berk M, Oates R, Zhao Z, Tan H, Jiang Y, Zhou A, Kirmani K, Steinmetz R, Lindner D, Xu Y.
    J Natl Cancer Inst; 2007 Sep 05; 99(17):1313-27. PubMed ID: 17728215
    [Abstract] [Full Text] [Related]

  • 33. Gastric cancer cells in collagen gel matrix: three-dimensional growth and differential expression of adhesion molecules (CD44s, CD54, E-cadherin).
    Jia Q, Feng M, Wang Y, Xue S.
    J Biomed Mater Res A; 2008 Mar 15; 84(4):917-25. PubMed ID: 17647231
    [Abstract] [Full Text] [Related]

  • 34. CD44s expression mitigates the phenotype of human colorectal cancer hepatic metastases.
    Pereira PA, Rubenthiran U, Kaneko M, Jothy S, Smith AJ.
    Anticancer Res; 2001 Mar 15; 21(4A):2713-7. PubMed ID: 11724345
    [Abstract] [Full Text] [Related]

  • 35. Soluble CD44 secretion contributes to the acquisition of aggressive tumor phenotype in human colon cancer cells.
    Subramaniam V, Gardner H, Jothy S.
    Exp Mol Pathol; 2007 Dec 15; 83(3):341-6. PubMed ID: 17945213
    [Abstract] [Full Text] [Related]

  • 36. CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas.
    Takahashi K, Stamenkovic I, Cutler M, Saya H, Tanabe KK.
    Oncogene; 1995 Dec 07; 11(11):2223-32. PubMed ID: 8570172
    [Abstract] [Full Text] [Related]

  • 37. Reduced tumor growth in vivo and increased c-Abl activity in PC3 prostate cancer cells overexpressing the Shb adapter protein.
    Davoodpour P, Landström M, Welsh M.
    BMC Cancer; 2007 Aug 15; 7():161. PubMed ID: 17697368
    [Abstract] [Full Text] [Related]

  • 38. Androgen receptor regulates CD168 expression and signaling in prostate cancer.
    Lin SL, Chang D, Chiang A, Ying SY.
    Carcinogenesis; 2008 Feb 15; 29(2):282-90. PubMed ID: 18174258
    [Abstract] [Full Text] [Related]

  • 39. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA, Harb JF, Barroso U, He Z, Grignon DJ, Cher ML.
    Cancer Res; 1999 Apr 15; 59(8):1987-93. PubMed ID: 10213511
    [Abstract] [Full Text] [Related]

  • 40. Expression of Nkx3.1 enhances 17beta-estradiol anti-tumor action in PC3 human prostate cancer cells.
    Wang P, Liu B, Luo JD, Zhang ZG, Ma Q, Chen ZD.
    Asian J Androl; 2007 May 15; 9(3):353-60. PubMed ID: 17486276
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.